All data are based on the daily closing price as of July 18, 2025
s
Seegene
096530.KQ
23.00 USD
-0.41
-1.75%
Overview
Last close
23.00 usd
Market cap
1.06B usd
52 week high
25.81 usd
52 week low
14.21 usd
Target price
30.9 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
3.3723
Price/Book Value
1.4854
Enterprise Value
767.34M usd
EV/Revenue
2.425
EV/EBITDA
11.2845
Key financials
Revenue TTM
316.42M usd
Gross Profit TTM
191.49M usd
EBITDA TTM
60.44M usd
Earnings per Share
N/A usd
Dividend
0.57 usd
Total assets
839.36M usd
Net debt
N/A usd
About
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.